Hi — I'm Alma
Hi — I'm Alma. I put this guide together for you because navigating the world of metabolic health can feel overwhelming, especially when you start hearing terms like "clinical trials" and "investigational therapies." Whether you're living with type 2 diabetes, managing your weight, dealing with fatty liver disease, or trying to get ahead of prediabetes, there's a lot happening in research right now — and some of it might be relevant to you.
This article is meant to give you a clear, honest picture of what metabolic conditions are, what researchers are studying today in the United States, and how to figure out whether joining a clinical trial could make sense for your situation. I'm not here to sell you on anything. I'm here to help you understand your options so you can make informed choices with your doctor.
Let's start with the basics.
What Are Metabolic Conditions?
When we talk about "metabolic" health, we're really talking about how your body converts food into energy, manages blood sugar, stores fat, and keeps your organs running smoothly. When that system gets out of balance, it can show up in several different ways. Here are the main conditions that fall under this umbrella:
Type 2 diabetes is probably the most well-known metabolic condition. It happens when your body either doesn't make enough insulin or doesn't use it effectively — a state called insulin resistance. Over time, blood sugar levels stay too high, and that can damage your heart, kidneys, nerves, and eyes. About 37 million Americans have diabetes, and roughly 90–95% of them have type 2. Many more have prediabetes, meaning their blood sugar is elevated but hasn't crossed the diabetes threshold yet.
Obesity is far more than a number on a scale. It's a complex, chronic condition involving how your body regulates appetite, stores energy, and responds to hormones. Obesity significantly raises the risk of type 2 diabetes, heart disease, certain cancers, and joint problems. It's influenced by genetics, environment, medications, sleep, stress — the list is long. More and more, the medical community recognizes obesity as a disease that deserves serious treatment, not just willpower advice.
Metabolic syndrome isn't a single disease — it's a cluster of risk factors that tend to travel together: high blood sugar, high blood pressure, excess abdominal fat, high triglycerides, and low HDL ("good") cholesterol. Having three or more of these dramatically increases your risk of heart disease, stroke, and type 2 diabetes. You can have metabolic syndrome without knowing it, which is why routine checkups matter.
MASH (metabolic dysfunction–associated steatohepatitis), formerly called NASH, and its earlier stage, NAFLD (non-alcoholic fatty liver disease), involve the buildup of fat in the liver that's not caused by alcohol. NAFLD is relatively common and often harmless on its own. But when it progresses to MASH, the liver becomes inflamed and scarred, potentially leading to cirrhosis or liver failure. MASH is closely tied to obesity, insulin resistance, and type 2 diabetes, and it's one of the fastest-growing reasons for liver transplants in the US.
These conditions are deeply interconnected. Having one often raises your risk for the others, which is why researchers and doctors increasingly think of metabolic health as a whole system rather than a set of separate diagnoses.
What's Happening in Research Right Now
There is a significant amount of clinical trial activity in the metabolic space across the United States. Right now, we're tracking 101 active trials focused on metabolic conditions — spanning obesity, type 2 diabetes, prediabetes, insulin resistance, fatty liver disease, and related cardiovascular complications.
These trials span the full research spectrum. 17 are Phase 3 trials, which are large-scale studies designed to confirm whether a treatment works and is safe enough for approval. 10 are Phase 2 trials, testing promising therapies in a more targeted group of patients. 9 are Phase 1 trials, which focus on safety and dosing in early development. 4 are Phase 4 trials, studying treatments that are already approved to learn more about real-world use and long-term effects. A large share of the studies — 61 — don't have a traditional drug phase designation, often because they're investigating behavioral interventions, diagnostics, lifestyle modifications, or mechanistic research rather than a specific medication.
The leading sponsor by a wide margin is Eli Lilly and Company, with 14 trials in our dataset. Lilly has been at the forefront of developing GLP-1 receptor agonist therapies and related incretin-based treatments for type 2 diabetes and obesity — a drug class that has transformed metabolic care in recent years. Amgen is also active with 4 trials, exploring treatments that intersect metabolic and cardiovascular disease.
Academic medical centers are driving a huge portion of the research. The University of Colorado, Denver and The University of Texas Health Science Center at San Antonio each sponsor 3 trials, including work on eating behaviors and hepatic metabolism in fatty liver disease. The University of Pennsylvania has 3 trials as well, including research into the genetic and behavioral drivers of childhood obesity. Yale University is investigating brain glucose transport in type 2 diabetes, and Mayo Clinic is studying exercise response in people with obesity.
The research isn't limited to new drugs. Across these 101 trials, you'll find studies on behavioral strategies for weight management, digital health tools (like mobile apps for diabetes self-management in underserved populations), sleep and metabolism connections, the role of NAD augmentation in diabetic kidney disease, and even how caloric restriction might affect cancer treatment outcomes in people with obesity. There's also important work on GLP-1 receptor agonists being tested for conditions beyond diabetes and weight — such as obesity-related asthma.
This breadth reflects how metabolic research has evolved. It's no longer just about blood sugar and weight — it's about the whole patient.
What This Means for You as a Patient
If you're living with a metabolic condition, the current wave of research means there may be options available to you beyond what's already on the pharmacy shelf. Clinical trials can offer access to investigational therapies, closer medical monitoring, and the chance to contribute to science that helps others down the road.
That said, a clinical trial isn't right for everyone, and it's important to go in with realistic expectations. Here are some questions worth considering:
- Is my current treatment working well enough? If you're stable and satisfied with your care, a trial may not be a priority. But if you're not seeing the results you need — or if side effects are limiting you — a trial could open new doors.
- What would participation actually look like? Trials vary widely. Some require frequent clinic visits; others are mostly remote. Some test a pill; others involve lifestyle coaching or wearable devices. Ask about the time commitment before you commit.
- What are the risks? Every trial involves some uncertainty — that's the nature of research. Make sure you understand what's known and what isn't about the treatment being studied.
- Will I definitely receive the study treatment? Many trials use a placebo or comparator group. Ask whether there's a chance you'll receive a placebo and what standard care looks like in the control arm.
- Who is the study team, and will I have support? A good trial site should feel like an extension of your care team, not a factory.
Talk to your doctor. Bring questions. And know that enrolling in a trial — or deciding not to — is entirely your choice.
How the Alma Triage Works
I built the Alma triage to make the first step easier. Instead of scrolling through databases full of jargon, you can visit our metabolic hub at almastudies.com/metabolic and start a short guided chat.
The chat will ask you a few straightforward questions — things like your general diagnosis, where you're located, and what kind of study you might be open to. Based on your answers, it matches you with trials from our curated list that could be a fit.
It's free, it takes just a few minutes, and it doesn't commit you to anything. No personal health records are collected or stored. Think of it as a conversation that helps you see what's out there — a starting point, not a finish line. If something looks interesting, you'll have the information you need to take the next step with your doctor or the study team.
Ready to See What's Available?
If you're curious whether there's a metabolic clinical trial that fits your situation, the easiest way to find out is to start the triage. It's quick, it's private, and it's built to respect your time.
Start the triage here → almastudies.com/metabolic
And if you're not ready yet, that's perfectly okay too. Bookmark this page, share it with someone who might benefit, or just come back when the timing feels right. I'll be here.